EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Role of miR‑181a‑5p in cancer (Review)

Junxin Li, Jing Shen, Yueshui Zhao, Fukuan Du, Mingxing Li, Xu Wu, Yu Chen, Shurong Wang, Zhangang Xiao, Zhigui Wu

International Journal of Oncology · 03.08.2023 · 63 (4)

DOI: 10.3892/ijo.2023.5556 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Oncology, online erschienen am 03.08.2023. Verfasst von Junxin Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China. Hauptthemen laut MEDLINE: MicroRNAs, Neoplasms. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MicroRNAs (miRNAs) are non‑coding RNAs (ncRNAs) that can post‑transcriptionally suppress targeted genes. Dysregulated miRNAs are associated with a variety of diseases. MiR‑181a‑5p is a conserved miRNA with the ability to regulate pathological processes, such as angiogenesis, inflammatory response and obesity. Numerous studies have demonstrated that miR‑181a‑5p exerts regulatory influence on cancer development and progression, acting as an oncomiR or tumor inhibitor in various cancer types by impacting multiple hallmarks of tumor. Generally, miR‑181a‑5p binds to target RNA sequences with partial complementarity, resulting in suppression of the targeted genes of miR‑181a‑5p. However, the precise role of miR‑181a‑5p in cancer remains incompletely understood. The present review aims to provide a comprehensive summary of recent research on miR‑181a‑5p, focusing on its involvement in different types of cancer and its potential as a diagnostic and prognostic biomarker, as well as its function in chemoresistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsNeoplasmsHumans

Stichwörter der Autor:innen

biomarkercancerschemoresistancemiR‑181a‑5p

Substanzen

MicroRNAs

Autor:innen und Institutionen

  • Department of Pharmacy, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.
  • Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.

Zitieren

APA

Li, J., Shen, J., Zhao, Y., Du, F., Li, M., Wu, X., Chen, Y., Wang, S., Xiao, Z., & Wu, Z. (2023). Role of miR‑181a‑5p in cancer (Review). International Journal of Oncology, 63(4). https://doi.org/10.3892/ijo.2023.5556

Vancouver

Li J, Shen J, Zhao Y, Du F, Li M, Wu X, et al. Role of miR‑181a‑5p in cancer (Review). International Journal of Oncology. 2023;63(4). doi:10.3892/ijo.2023.5556

BibTeX
@article{Li2023,
  author = {Li, Junxin and Shen, Jing and Zhao, Yueshui and Du, Fukuan and Li, Mingxing and Wu, Xu and Chen, Yu and Wang, Shurong and Xiao, Zhangang and Wu, Zhigui},
  title = {Role of miR‑181a‑5p in cancer (Review)},
  journal = {International Journal of Oncology},
  year = {2023},
  volume = {63},
  number = {4},
  doi = {10.3892/ijo.2023.5556}
}
Kostenlos starten →